---
title: "Azapropazone - Ankylosing spondylitis"
sidebar: mydoc_sidebar
permalink: db07402-mesh-d013167-1.html
toc: false 
---


Path ID: `DB07402_MESH_D013167_1`
{% include image.html url="images/db07402-mesh-d013167-1.png" file="db07402-mesh-d013167-1.png" alt="db07402-mesh-d013167-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001032 | Azapropazone | Drug |
| UniProt:P23219 | Prostaglandin G/H synthase 1 | Protein |
| UniProt:P35354 | Prostaglandin G/H synthase 2 | Protein |
| MESH:D011453 | Prostaglandins | ChemicalSubstance |
| GO:0006954 | Inflammation | BiologicalProcess |
| MESH:D013167 | Ankylosing spondylitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Azapropazone | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 1 |
| Azapropazone | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 2 |
| Prostaglandin G/H Synthase 1 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandins | POSITIVELY CORRELATED WITH | Inflammation |
| Inflammation | CAUSES | Ankylosing Spondylitis |
|---------|-----------|---------|

Comment: Withdrawn

Reference: [https://go.drugbank.com/drugs/DB07402#mechanism-of-action](https://go.drugbank.com/drugs/DB07402#mechanism-of-action){:target="_blank"}